Bellini A, Keegan T H M, Li Q, Jacinto A, Maguire F B, Lyo V, Sauder C A M
Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA.
Department of Surgery, University of California Davis School of Medicine, Sacramento, CA, USA.
Breast Cancer Res Treat. 2025 Jun;211(3):649-656. doi: 10.1007/s10549-025-07678-7. Epub 2025 Mar 10.
Underweight women and those with obesity, defined as having a body mass index (BMI) ≥ 30 kg/m, diagnosed with breast cancer (BC) are known to have worse prognosis. Whether BMI impacts BC stage at diagnosis and BC specific survival (BCSS) is not understood. We aim to better understand the relationship between BMI with stage at BC diagnosis and BCSS.
Women age ≥ 15 years old diagnosed with BC between 2014 and 2019 were identified from the California Cancer Registry. BMI at diagnosis was classified as underweight (< 18.5 kg/m), normal weight (18.5-24.9 kg/m), overweight (25-29.9 kg/m), obesity class 1-2 (30-39.9 kg/m), and obesity class 3 (≥ 40 kg/m). BC late stage of diagnosis was defined as American Joint Committee on Cancer stage 3 and 4. Multivariate logistic regression was performed to compare sociodemographic and clinical factors associated with late stage. Multivariable cox proportional hazards regression models assessed association of BMI and BCSS.
Of 159,248 patients: 2.2% were underweight, 34.6% normal weight, 30.5% overweight, 26.7% obesity class 1-2, and 6.0% obesity class 3. Compared to normal weight, patients who were underweight [Hazard Ratio (HR) 1.54, 95% Confidence Interval (CI) 1.51-1.57], obesity class 1-2 [HR 1.06, 1.05-1.07], and obesity class 3 [HR 1.14, 1.12-1.16] were more likely to be diagnosed with late-stage BC. In models stratified by age, patients ≥ 40 years who were underweight had worse BCSS, while patients ≥ 51 years with obesity class 1-2 had better BCSS.
Patients with obesity class 1-2 were more likely to be diagnosed with a later stage, but had improved BCSS, supporting an "obesity paradox" in BC and suggesting that other measures are needed to better assess body composition, adipose distribution, and metabolic health of patients. Patients who were underweight had worse survival, suggesting this high-risk group may benefit from being assessed and treated for possible sarcopenia and malnourishment.
体重过轻的女性以及被定义为体重指数(BMI)≥30kg/m²的肥胖女性被诊断患有乳腺癌(BC)时,其预后较差。目前尚不清楚BMI是否会影响乳腺癌诊断时的分期以及乳腺癌特异性生存率(BCSS)。我们旨在更好地了解BMI与乳腺癌诊断分期和BCSS之间的关系。
从加利福尼亚癌症登记处识别出2014年至2019年间被诊断患有乳腺癌的年龄≥15岁的女性。诊断时的BMI被分类为体重过轻(<18.5kg/m²)、正常体重(18.5 - 24.9kg/m²)、超重(25 - 29.9kg/m²)、1 - 2级肥胖(30 - 39.9kg/m²)和3级肥胖(≥40kg/m²)。乳腺癌晚期诊断定义为美国癌症联合委员会分期3期和4期。进行多变量逻辑回归以比较与晚期相关的社会人口统计学和临床因素。多变量Cox比例风险回归模型评估BMI与BCSS的关联。
在159,248名患者中:2.2%体重过轻,34.6%体重正常,30.5%超重,26.7%为1 - 2级肥胖,6.0%为3级肥胖。与正常体重相比,体重过轻的患者[风险比(HR)1.54,95%置信区间(CI)1.51 - 1.57]、1 - 2级肥胖患者[HR 1.06,1.05 - 1.07]和3级肥胖患者[HR 1.14,1.12 - 1.16]更有可能被诊断为晚期乳腺癌。在按年龄分层的模型中,≥40岁体重过轻的患者BCSS较差,而≥51岁的1 - 2级肥胖患者BCSS较好。
1 - 2级肥胖患者更有可能被诊断为晚期,但BCSS有所改善,这支持了乳腺癌中的“肥胖悖论”,并表明需要采取其他措施来更好地评估患者的身体成分、脂肪分布和代谢健康。体重过轻的患者生存率较差,这表明这一高危群体可能受益于对可能的肌肉减少症和营养不良进行评估和治疗。